Advertising Ban, New Regulation of Blood Products and Biologicals
29 Jun 2018
Platelet-rich plasma (PrP) and stem cell treatment are included in an advertising ban from 1 July 2018, following new TGA regulation which covers all autologous human cell and tissue (HCT) products.
Autologous HCT products have not previously been regulated by the TGA. Concerns about patient safety and the advertising of unproven interventions led to the new regulations, which will bring Australia into line with the United States and the European Union.
Under the regulation autologous HCT products cannot be advertised to the public. Advertising cannot reference specific autologous HCT products, trade names (including abbreviations or acronyms) or colloquial names such as 'stem cells'. Services can be advertised if they do not mention specific products.
Autologous HCT products manufactured and used outside an accredited hospital will be regulated as either:
- A medicine: minimally manipulated, homologous use products for a patient in the same practitioner's care (PrP may meet these criteria). Requirements include complying with standards and reporting adverse events to the TGA.
or
- A biological: more than minimally manipulated, non-homologous use products (eg conditioned serum, adipose-derived cell extract). Requirements include complying with standards, reporting adverse events to the TGA, recording and reporting conditions, inclusion in the ARTG, and licensing and certification.
The TGA has provided guidance on the new regulations, and a one-year transition period will allow providers time to align with the new regulatory requirements.
Products manufactured and used in an accredited hospital (eg skin grafts, vascular conduits and autologous blood to seal CSF leaks) are excluded from regulation.
Access to 'unapproved' autologous HCT products will still be available, subject to approval, for clinical trials, the Special Access Scheme and authorised prescribers.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Doctors Let's Talk: Get Yourself A Fricking GP
Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.
25 Oct 2022
Systematic efforts to reduce harms due to prescribed opioids – webinar recording
Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme.
14 May 2021
Diplomacy in a hierarchy: tips for approaching a difficult conversation
Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.
05 Oct 2020
